Board -2021 -Mtg -1-Doc 0 4 1
Report to the Board
22 March 20 21

















SUBJECT: GAVI COVAX AMC
Agenda item: 04
To follow

1



Board -2021 -Mtg -1-Doc 0 3



Section A: Summary
Context
In December 2020, the Gavi Board approved the concept of the COVAX Buffer
with its dual purpose to ensure acces s to COVID -19 vaccines for high -risk
populations in humanitarian settings (the ?Humanitarian Buffer?); and to provide a
contingency provision to enable an emergency release of doses to help m itigate
the most severe clusters of high mortality where normal v accine allocation
timelines may not be sufficient (the ?Contingency Provision?). The Board asked
the Secretariat to consult with the Programme & Policy Committee (PPC) to
further develop the details of the COVAX Buffer prior to approval of the high -level
parameters and funding needs. Given the widespread calls for urgency to
implement the Humanitarian Buffer, and the ev olution of thinking on the
Contingency Provision whereby it will only be relevant after end June 2021, the
Secretariat is now bringing forwa rd the Humanitarian Buffer for review and
approval by the Board.
Questions this paper addresses
What are the pr oposed target populations for the Humanitarian Buffer?
Which entities are proposed to be eligible to apply to the Humanitarian Buffer?
How is it proposed that the doses for the Humanitarian Buffer and associated
delivery costs be f unded?
What is the proposed decision -making process for allocating Humanitarian
Buffer doses?
Conclusions
In March 2021 the PPC recommended to the Gavi Board that , no tin g the scope
of the Humanitarian Buffer , it (i) approve reserving 5% of Gavi COVAX AMC
(?AMC?) funding for doses to be deployed via the COVAX Buffer ; approve an
amendment to expand where previously approved exceptional delivery funding
can be used and to as sign 5% of this delivery funding to the Humanitarian Buffer ;
(iii) approve the delegation of decision making on the allocation of Humanitarian
Buffer doses to the Inter -Agency Standing Committee (IASC) Emergency
Directors Group ; and (iii) approve that the Secretaria t report back to the PPC and
Board on the operation of the Humanitarian Buffer.
SUBJECT: COVAX BUFFER FOR HIGH -RISK GROUPS IN
HUMANITARIAN SITUATIONS
Agenda item: 03
Category: For Decision
Report to the Board
22 March 202 1

March 202 1
COVAX AMC ENGAGEMENT GROUP
TERMS OF REFERENCE
1. Purpose
The COVAX Facility A dvance M arket C ommitment (?AMC?) Engagement Group (?the A MC
Group ?) is established by the Board (?Board?) of the Gavi Alliance (?Gavi?) to convene
representatives from implementing countries, donors and other parties engaged in the
financing and operation of the AMC portion of the Facility , with the aim of providing st rategic
guidance and advice to the Office of the COVAX Facility (?the Office?) on the operational
aspects of the COVAX Facility .
The AMC Group i s not deemed to be a committee of the Board in that its primary role is
essentially an advisory function as contemplated under Article 20 of the Statues. It is
empowered by the Board to undertake the responsibilities outlined in these terms of
reference.
2. Membership
A. Composition and size
Membership of the AMC Group will be open to representatives of implementing countries,
donors and other parties engaged in the financing and operation of the AMC portion of the
Facility.
Additionally, a representative each from UNICEF, WHO, PAHO, the World Bank and Civil
Society shall have a permanent observer seat on the Engagement Group .
All members are treated equally in terms of membership, rights and privileges .
B. Competencies and skills
All members are expected to act in a manner consistent with the Facility?s goals.
The criteria for AMC Group membership shall be consistent with Gavi?s guiding principles on
gender for Board and Board Committee nominations and Gavi?s Conflicts of Interest Policy for
Governance Bodies.
Doc 01c - Annex A

Board -2021-Mtg -1-Doc 00a




G avi Alliance Board Meeting
22 March 202 1
Virtual Meeting

Mond ay 22 March : 14.00-17.30 Geneva Time
Quor um: 14

Document list

No. Document
00a Document list
00b Agenda
01a Declarations of interest
01b No Objection Consent Decisions
01c Consen t Agenda
02 CEO ?s Report ? No paper
03 COVAX buffer for high -risk groups in humanitarian situations
04 Gavi COVAX AMC (To follow)
05 Review o f decisions ? No paper
06 Closing remarks ? No paper

1



Board -2021 -Mtg -1-Doc 01c
Report to the Board
22 March 2020

Section A: Introduction
One recommendations is being presented to the Board under the Consent Agenda
for consideration. Detailed information on the item can be found in the relevant
Committee paper in a dedicated folder on BoardEffect at :
https://gavi.boardeffect.co.uk/workrooms/6459/resources/107720
Section B: Actions requested of the Board
The Gavi Alliance Board is requested to consider the following recommendation
from the Gavi Alliance Governance Committee .
Decision One ? COVAX Facil ity Terms of Reference
The Gavi Alliance Governance Committee recommen ds to the Gavi Alliance
Board that it:
Approve the Terms of Reference of the COVAX AMC Engagement Group
attached as Annex A to Doc 01 c.
SUBJECT: CONSENT AGENDA
Agenda item: 01 c
Category: For Decision

Board -2021-Mtg-1-Doc 00b
Classifie d as Restricted



G avi Alliance Board Meeting
22 March 2021 , Virtual Meeting

Monday 22 March : 14.00 -17.30 Geneva Time
Quorum: 14

Agenda

Item Sub ject Action Schedule

1 Chair?s report
? Declarations of interest
? No Objection Cons ent Decisions
? Co nsent Age nda 1
Jos ? Manuel Barroso , Board Chair
DECISIO N 14.00 -14. 30
2 CEO? s Report
? CEO ?s Report: Seth Berkley, Chief Executive Officer
? Discussion
14 .30 -15. 30
3 COVAX Buffer for high -risk group s in humanitarian
situations
Aur ?lia Nguyen, Managing Director , Offi ce of the COVAX
Facility
DE CISION 15. 30 -16.10
Break 16.10 -16.20
4 Gavi COVAX AMC
Marie -Ange Saraka -Yao , Managing Director, Resource
Mobilisatio n, Pr ivate Sector Partnership s and Innovative Finance
16. 20 -16.50
5 Review o f decis io ns
Brenda Killen , Director, Gove rnance
16. 50 -16.55
6 Closing remarks
Jos ? Manu el Barroso , Board Chair
16. 55 -17.00
Closed Session: For Board Members and Alternate Board
Members only
17.00 -17.30

Ne xt Board Meeting s: 23-24 June 202 1
28 September 2021
1-2 December 202 1 ---
Brend a Killen , Directo r, Governance and Secretary t o the Board, +41 22 9 09 6 680, bkillen @gavi.org
Jo anne Goetz , Head, Governance, + 41 22 909 6544, jgoetz@gavi.org
Please note that th e Board meeting w ill be recorded. This recording will be used as an aid to minute the meeting .
A transcr iptio n of the full proceedings will not normally be made. Shou ld a transcription be made it wil l be us ed
only as an aid to minute the meeting .

1 Any Board m ember can a sk that an y item be removed fro m the consent agenda for f urth er dis cussion. S hould
there be any such request, the relevant discussion will take place immedia tely precedin g th e R evie w of
Decisi ons.

Download: English | French | Spanish | Chinese | Arabic | Italian | German